The store will not work correctly when cookies are disabled.
3-((diallylamino)methyl)-2-methylquinolin-4-ol
ID: ALA4856427
PubChem CID: 720679
Max Phase: Preclinical
Molecular Formula: C17H20N2O
Molecular Weight: 268.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCN(CC=C)Cc1c(C)nc2ccccc2c1O
Standard InChI: InChI=1S/C17H20N2O/c1-4-10-19(11-5-2)12-15-13(3)18-16-9-7-6-8-14(16)17(15)20/h4-9H,1-2,10-12H2,3H3,(H,18,20)
Standard InChI Key: PKMKEMIYJSQJSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
24.6135 -3.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9005 -3.9158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8967 -4.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6020 -5.1495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3182 -3.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3093 -4.7446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0119 -5.1593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7238 -4.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7288 -3.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0256 -3.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1872 -5.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1955 -3.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2008 -2.6855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4958 -2.2722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9112 -2.2815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6162 -2.6947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9165 -1.4643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6269 -1.0604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7854 -2.6762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0804 -2.2630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
3 11 1 0
1 16 1 0
2 12 1 0
12 13 1 0
13 14 1 0
13 15 1 0
15 17 1 0
17 18 2 0
14 19 1 0
19 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.36 | Molecular Weight (Monoisotopic): 268.1576 | AlogP: 3.42 | #Rotatable Bonds: 6 |
Polar Surface Area: 36.36 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.62 | CX Basic pKa: 7.88 | CX LogP: 3.17 | CX LogD: 2.69 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.82 | Np Likeness Score: -0.94 |
References
1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L.. (2021) Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2., 38 [PMID:33862469] [10.1016/j.bmc.2021.116115] |